Introduction: There are several important interactions between antiepileptic drugs (AEDs) and hormonal contraception that need to be carefully considered by women with epilepsy (WWE) and their practitioners. Many AEDs induce hepatic enzymes and decrease the efficacy of hormonal contraception. In addition, estrogen-containing hormonal contraception can increase the metabolism of lamotrigine, the most commonly prescribed AED in women of childbearing age. The intrauterine device (IUD) is a highly effective form of reversible contraception without AED drug interactions that is considered by many to be the contraceptive of choice for WWE. Women with epilepsy not planning pregnancy require effective contraceptive counseling that should include discussion of an IUD. There are no guidelines, however, on who should deliver these recommendations. The objective of this study was to explore the hypothesis that contraceptive counseling by a neurologist can influence the contraceptive choices of WWE. In particular, we explored the relationship between contraceptive counseling in the epilepsy clinic and the likelihood that patients would obtain an IUD. Methods: We conducted a retrospective chart review of female patients age 18-45 seen at our institution for an initial visit between 2010 and 2014 to ascertain the type of contraceptive counseling each patient received as well as AED use and contraceptive methods. Patients who were pregnant or planning pregnancy at the first visit were excluded from further analyses as were patients with surgical sterilization. We also examined a subgroup of 95 patients with at least 4 follow-up visits to evaluate the efficacy of epileptologists' counseling. Specifically, we looked at the likelihood a patient obtained an IUD based on the type of counseling she had received. Fisher exact tests assessed associations between counseling type and whether patients had obtained an IUD. Results: Three hundred and ninety-seven women met criteria for inclusion. Only 35% of female patients were counseled about contraception at the first visit. If women were not counseled at the first visit, they were unlikely to be counseled at subsequent visits; only 37% had ever received counseling by their fourth visit. Of the 95 patients who completed 4 visits, 28.4% were counseled about an IUD as an optimal contraceptive choice, 38.9% were generally counseled about contraceptive interactions, and 32.6% were not counseled about contraception. Women with epilepsy who received IUD-specific counseling were significantly more likely to switch to an IUD (44.4%) compared with women who received no contraceptive counseling (6.5%; p = 0.0009). Women with epilepsy who received IUD-specific counseling also tended to switch to an IUD more often than those women receiving general counseling about AEDs and contraceptive interactions (18.9%; p = 0.027). There was no significant difference in the likelihood of acquiring an IUD between the general counseling and no counseling groups. Conclusions: Contraceptive counseling by epileptologists and specific mention of an IUD is significantly associated with patient selection of an IUD as a contraceptive method. This suggests that neurologists can play an important role in patients' contraceptive choices.
Antiepileptic drugs and hormonal contraception
Epilepsy affects 0.5-1% of the population, and 33% of these individuals are women of childbearing age [1] . It is critical that women with epilepsy (WWE) plan their pregnancies in advance in order to minimize the teratogenic risk of antiepileptic drugs (AEDs) and optimize seizure control prior to getting pregnant. Thus, understanding and obtaining an optimal form of contraception is an important part of their health management early in their care.
Obtaining appropriate contraception is complicated for WWE given the bidirectional interactions between hormonal contraceptives and the majority of AEDs. Enzyme-inducing AEDs (EI-AEDs) including carbamazepine, perampanel, phenobarbital, phenytoin, and primidone are potent inducers of hepatic P450 microsomal enzymes. In addition, they may increase sex hormone-binding globulin (SHBG) production. Both mechanisms result in decreased bioactive sex hormone levels and reduce the effectiveness of hormonal contraception [2] . Clobazam, eslicarbazepine, felbamate, lamotrigine, oxcarbazepine, and topiramate induce P450 enzymes to a lesser degree but may also decrease sex steroid concentrations and the efficacy of hormonal contraception [2, 3] .
Estrogen-containing contraceptives such as the combined oral contraceptive pills (COC), the vaginal ring, and patch enhance the glucuronosyltransferase system resulting in increased metabolism and lower serum concentrations of glucuronidated drugs including lamotrigine and valproic acid [4] [5] [6] .
Contraceptive recommendations for WWE
According to consensus statements from a World Health Organization (WHO) working group and the Center for Disease Control (CDC), combined oral contraceptive pills and progesterone only pills, as well as contraceptive patches and vaginal rings are not recommended as first-line contraception in women taking EI-AEDs [2, 7] .
The statements mention that depot medroxyprogesterone and the levonorgestrel implant can be considered in women taking EI-AEDs; however, contraceptive failure has been reported when the levonorgestrel implant was used in combination with EI-AEDs [2, 7] .
These statements from the WHO working group and the CDC as well as other authors also recommend against combining lamotrigine and estrogen-containing birth control methods (COCs, orthoevra patch, and nuva ring) because of the risk of loss of seizure control [2, 7] . While, in practice, fluctuations in lamotrigine levels can be avoided by an experienced neurologist or epileptologist, it is preferable to avoid this variability.
An intrauterine device (IUD) is recommended as the contraceptive of choice for WWE [3, 8, 9] . The IUD avoids all of the above drug-drug interactions between contraception and AEDs. Additionally, the IUD is an exceptionally effective form of contraception with a failure rate of 0.2-0.8% per year, which is superior to most hormonal contraceptive methods and nonhormonal barrier methods such as male condoms which with 'typical use' have a failure rate of 18% [10] . While it was once thought that the IUD could only be used after childbirth, the IUD is now recommended as a first-line contraceptive choice for teenage girls by the American Academy of Pediatrics [11] . The IUD does not require consistent compliance as is needed with barrier methods or the depot medroxyprogesterone injection. The copper IUD is approved for 10 years, and the 52-mg and 13.5-mg levonorgestrel IUDs are approved for 5 and 3 years, respectively. Both the copper and levonorgestrelcontaining IUDs can be considered for WWE. The progestin, levonorgestrel, in the levonorgestrel IUD, is thought to exert its effect locally and not be subject to drug-drug interactions. In one study of 56 women using the 52-mg levonorgestrel-containing and EI-AEDs, the failure rate was 1.1% per year [12] .
Contraceptive counseling
Counseling WWE about drug interactions and contraception is necessary to prevent unintentional pregnancy and avoid breakthrough seizures. However, there are no guidelines stating who is responsible for relaying this critically important information to the patient. The aim of the current study was to document the current contraceptive counseling practices of epileptologists at our institution and to investigate whether counseling by a neurologist was effective in influencing the contraceptive choices of WWE. In particular, we chose to focus on the association between epileptologists' counseling and patient selection of an IUD, the most efficacious form of reversible birth control.
Methods
All study procedures were approved by the Northwestern University Institutional Review Board. The study patients were women of childbearing age (18-45 years) seen as new patients in the Northwestern University epilepsy clinic from 2010 to 2014. This cohort was selected from all patients seen in our epilepsy clinic by Electronic Data Warehouse (EDW) using the search terms "new patient", "female", "2010 to 2014", and age "18 to 45". Data were extracted by manual chart review for each patient from the first visit and up to 4 subsequent visits depending on the number of follow-up appointments the patient attended. The electronic medical record included a new patient intake form with information regarding the patient's sexual and reproductive history, plans for pregnancy, current medications, and birth control which was used as an adjunct to the information documented in the visit progress note. Patients were excluded based on information documented in the first visit progress note or intake form. The exclusion criteria included the following: surgical sterilization, current pregnancy, or currently trying to become pregnant ( Fig. 2. 
1.1).
For each visit, AED use and contraceptive methods as well as counseling by the epileptologist were recorded as documented in the patient's visit progress note. Counseling documentation was placed into 1 of 3 groups: no counseling, general counseling, or IUD counseling.
"No counseling" -the physician did not document the occurrence of counseling during the visit about interactions between AEDs and contraceptives nor did the physician select "counseled about contraceptive drug interactions" from the discussion dropdown menu in the epilepsy template.
"General counseling" -physician documented discussion about contraception interactions in the visit note without specific mention of an IUD, or "counseled about contraceptive drug interactions" was selected from the discussion dropdown menu in the epilepsy template.
"IUD counseling" -physician documented in the visit note that an IUD was mentioned to the patient during contraceptive counseling.
A subgroup of female patients who had 4 visits at the epilepsy clinic between 2010 and 2014 was used to investigate the effectiveness of the current contraceptive counseling practices (Fig. 2.1.1 ). These women were divided into 3 groups based on the type of counseling they received at visit 1 or 2 as described above. The outcomes at visit 4 were documented as 1) changed to an IUD or 2) did not change to an IUD. Women who already had IUDs at the first visit were excluded from this efficacy cohort.
Statistical analysis
The presence or absence of counseling was documented for each visit and is presented using descriptive statistics. Fisher exact tests with 2x2 contingency tables were used to test the hypothesis that counseling type (no counseling, general counseling, or IUD counseling) was associated with patients' selection of an IUD for contraception. After Bonferroni correction for multiple comparisons a p value of b0.0125 was used to determine statistical significance.
Results

Patient population
Three hundred and ninety-seven new female patients seen in our epilepsy clinic between 2010 and 2014 met criteria for inclusion in this study. Fig. 2.1.1 demonstrates the total population included at each visit and numbers and reasons for exclusion. The patients ranged in age from 18 to 44 with an average age of 28 ± 7.3 years. The average time to complete four visits was 14 ± 8.2 months with an average time between visits of 5.3 ± 4.8 months.
At the first visit, AED monotherapy was the most common type of treatment regimen (47%) followed by polytherapy (28%). Twenty-five percent were not taking AEDs at the time of the first visit. By the fourth visit, the majority of women were receiving polytherapy (51%) with a similar percentage on monotherapy (48%). Only 3% of the patients completing 4 visits were not prescribed AEDs (Fig. 4.1.1) . At the fourth visit, the majority of patients (66%) were taking an AED with known interaction with hormonal contraception: lamotrigine (45%), an EI-AED other than lamotrigine (20%), or both (11%). Six percent were taking valproic acid. Further, 51% of women changed their AED therapy at least once over the course of 4 visits.
Birth control use
At the first visit, just over half of the women (53%) reported using some form of contraception (Table 4. 1.2) . However, 16% of women reported using no birth control, and data about birth control use and preference were not available for 31.5% of the women as shown in Table 4 .1.2 below. Of women taking AEDs at the first visit, 14% reported using condoms, 20% reported no current birth control method, and another 33% did not have contraceptive choice documented in the chart.
Contraceptive counseling
Of the 397 women who met criteria for the study, only 35% received contraceptive counseling (either "general" or "IUD counseling") at the first visit (Fig. 4.1.3) . Further, women who were not counseled at the first visit were unlikely to be counseled at subsequent visits; only 26 counseling-naïve women received counseling at a follow-up visit (Fig. 4.1.3 ).
Contraceptive counseling effectiveness
Women who attended 4 visits between 2010 and 2014 were included in the efficacy cohort analysis to determine contraceptive counseling effectiveness. Counseling group (IUD counseling, general counseling, or no counseling) was determined by physician documentation as previously described in the Methods section.
Patients who were specifically counseled about an IUD were significantly more likely to change their contraceptive method to an IUD compared with those who were never counseled (p = 0.0009) (Fig. 4.1.4) . Those who received IUD-specific counseling were also more likely to get an IUD than those who received general counseling (p = 0.027), although this did not reach strict statistical significance. The comparison between general and no counseling was not significant (p = 0.167). Analyses were repeated after excluding women who stated that they were not sexually active (n = 14), and the effect of IUD counseling remained significant (p = 0.001) when compared with no counseling.
Discussion
Women with epilepsy, particularly those of childbearing age, require contraceptive counseling as interactions between AED and birth control may result in changes in seizure frequency or unplanned pregnancy. Many women are unaware of these important drug-drug interactions and their clinical implications [13] . However, there are no current guidelines designating which providers are responsible for conveying this important information.
In this study, WWE were variably counseled about interactions between AEDs and hormonal birth control methods at a single academic epilepsy center. Women who were specifically counseled about an IUD as an optimal form of birth control by their epileptologist were more likely to obtain an IUD than those who were not counseled about contraception. Those who were generally counseled about drug-drug interactions and contraception by their epileptologist also tended to obtain IUDs more frequently than those who received no counseling at all. This suggests that neurologists may play an important role in patients' contraceptive choices.
It is easy to presume that patients may get appropriate counseling from their gynecologist or other primary care providers, but this may not be the case. The fact that only 6.5% of the women not receiving counseling about an IUD in the epilepsy clinic elected to obtain an IUD suggests that these patients are not learning about or are encouraged to pursue this important option by other practitioners. Prior research has suggested that many gynecologists are not knowledgeable about the interactions between AEDs and hormonal contraception [14] . Moreover, these physicians may not be made aware when a patient changes from a nonenzyme-inducing AED to an enzyme-inducing AED.
Another important finding of our study is that contraceptive counseling is most likely to occur at the first visit. Women were much less likely to be counseled at subsequent visits, and 62% of women who attended a fourth visit remained counseling-naïve. This is important because, even if a woman is not on a drug with significant contraceptive interactions early in her treatment, her regimen is likely to change. In our study, 51% of women changed their AED therapy at least once over the course of four visits, and by the fourth visit, 66% of women were taking an AED with known interaction with hormonal contraception. Furthermore, 6% were taking valproic acid, which is associated with significant structural and cognitive teratogenesis. Many AED changes occurred between visits without the opportunity for contraceptive counseling. Thus, contraceptive counseling should be accomplished at least at the first visit even if a patient is not sexually active or has not yet been prescribed an AED that may interact with hormonal contraception. Early counseling increases patients' awareness that AEDs and contraceptive changes are relevant throughout the course of their treatment during which several variables are likely to change.
This study focused on the recommendation of an IUD in order to explore a direct association between one specific contraceptive recommendation from a patient's neurologist and their contraceptive choice. The IUD was selected because it is the most effective form of reversible contraception [10] , and experts agree that an IUD should be considered the contraceptive of choice for the majority of women with epilepsy [3, 8, 9 ]. An IUD is a good option for women who are not yet on a stable AED regimen as it may avoid drug-drug interactions that arise with future AED changes, which we found to be frequent in our cohort. However, the IUD may not be the ideal contraceptive for every woman. There are other forms of contraception, such as depot medroxyprogesterone, that do not have significant drug-drug interactions and may be better options for some patients. We suspect that effective contraceptive counseling is individualized and may lead to different choices in certain patients. Nevertheless, our study suggests that a discussion of specific contraceptive options by an informed neurologist is likely associated with improved contraceptive decision-making and more effective choices. Birth control methods at first visit (n = 397). Methods are listed from most to least common with oral contraceptive pills being the most common documented method. IUD = intrauterine device.
Birth control method
Number of patients (% of total, n = 397) There are some limitations of the study inherent to the retrospective chart review methodology. This study relies on accurate documentation of birth control methods including documentation of an IUD. Certain women may have been less likely to report on contraceptive use or be counseled about contraception for reasons that could not be assessed retrospectively. It is also possible that those patients who were more open or interested in discussing contraceptive practices were more likely to change to an IUD. Additionally, because we wanted to make sure that we allowed sufficient time for patients to schedule appropriate follow-up and institute a change in contraception, we limited this part of the analysis to patients who had a total of 4 visits from 2010 to 2014. This methodology may have selected for parents who were more likely to follow recommendations as opposed to those patients who missed follow-up appointments or had less regular visits. However, this should have affected all counseling groups in a similar manner. Lastly, we suspect that the epileptologist's role can be extrapolated to other nonspecialty neurologists; however, because this study was conducted at a single epilepsy specialty clinic, it is possible that it is not generalizable for all neurology and epilepsy clinic settings.
Keeping these limitations in mind, this study suggests that contraceptive counseling and documentation are not consistent and could be improved. This is likely not limited to our center; in fact, the recently published findings of The Epilepsy Birth Control Registry found that only 25.4% of WWE consulted a neurologist about their contraceptive choice [15] . An earlier survey of WWE found that only 55% of women had discussed contraception with a healthcare provider and the discussion was initiated by the healthcare provider only 27% of the time [16] . Over 36% of the women in this survey desired more information about contraception and AEDs.
Our study demonstrates an association between the documentation of contraceptive counseling and patient selection of an IUD, a highly effective form of contraception without significant drug-drug interactions. This suggests that neurologists can play an important role in contraceptive counseling for WWE and that these patients may not be receiving this counseling from other sources. Accordingly, we propose that contraceptive counseling for WWE should be performed by their neurologist as well as their gynecologist and primary care providers and each group of practitioners should apprise themselves of the information needed to provide this important part of patient care. Formal guidelines and education for neurologists on contraception for WWE may help them provide this important counseling.
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